Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Free Fatty Acid Receptor 2 (FFAR2), also known as GPR43, is a G-protein coupled receptor primarily activated by short-chain fatty acids (SCFAs) like acetate, propionate, and butyrate. It plays a key role in glucose/insulin regulation, immune modulation, and lipid metabolism. FFAR2 is considered a therapeutic target for metabolic disorders such as diabetes and obesity.
Agonists/antagonists modulate receptor activity, influencing downstream signaling pathways involved in glucose homeostasis, immune response, and lipid metabolism.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Free fatty acid receptor 2 (FFAR2).